Swiss National Bank Lowers Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Swiss National Bank cut its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 8.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,600 shares of the company’s stock after selling 2,800 shares during the quarter. Swiss National Bank’s holdings in U.S. Physical Therapy were worth $2,757,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of USPH. Quantbot Technologies LP purchased a new stake in shares of U.S. Physical Therapy in the third quarter worth approximately $82,000. International Assets Investment Management LLC grew its holdings in shares of U.S. Physical Therapy by 9,269.0% in the fourth quarter. International Assets Investment Management LLC now owns 2,717 shares of the company’s stock valued at $253,000 after acquiring an additional 2,688 shares in the last quarter. HighTower Advisors LLC grew its holdings in shares of U.S. Physical Therapy by 47.2% in the third quarter. HighTower Advisors LLC now owns 2,773 shares of the company’s stock valued at $257,000 after acquiring an additional 889 shares in the last quarter. Channing Capital Management LLC bought a new position in shares of U.S. Physical Therapy in the third quarter valued at approximately $286,000. Finally, Envestnet Portfolio Solutions Inc. bought a new position in shares of U.S. Physical Therapy in the third quarter valued at approximately $298,000.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $103.10 on Thursday. The stock has a fifty day simple moving average of $105.38 and a two-hundred day simple moving average of $97.84. U.S. Physical Therapy, Inc. has a 1-year low of $78.08 and a 1-year high of $124.11. The firm has a market cap of $1.55 billion, a price-to-earnings ratio of 83.82, a price-to-earnings-growth ratio of 4.02 and a beta of 1.39. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.28.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.07). U.S. Physical Therapy had a net margin of 4.72% and a return on equity of 8.03%. The firm had revenue of $155.70 million for the quarter, compared to the consensus estimate of $153.30 million. During the same period last year, the company posted $0.59 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 4.8% on a year-over-year basis. Analysts anticipate that U.S. Physical Therapy, Inc. will post 2.9 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Thursday, May 23rd will be given a dividend of $0.44 per share. The ex-dividend date is Wednesday, May 22nd. This represents a $1.76 annualized dividend and a dividend yield of 1.71%. U.S. Physical Therapy’s dividend payout ratio is currently 143.09%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 2,500 shares of the stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $107.57, for a total transaction of $268,925.00. Following the sale, the director now owns 3,280 shares in the company, valued at $352,829.60. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 2,500 shares of the stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $107.57, for a total transaction of $268,925.00. Following the sale, the director now owns 3,280 shares in the company, valued at $352,829.60. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total value of $193,104.00. Following the sale, the chief financial officer now owns 21,186 shares in the company, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. Insiders have sold a total of 17,553 shares of company stock worth $1,852,823 over the last 90 days. Corporate insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Barrington Research reaffirmed an “outperform” rating and issued a $122.00 target price on shares of U.S. Physical Therapy in a report on Thursday, May 9th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Monday, March 18th. Finally, JPMorgan Chase & Co. upped their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a report on Wednesday, March 13th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and a consensus target price of $125.67.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.